SUPPLEMENT

H1 FY2024 — Additional analyst information

H1 FY2024PDF · 14 pages511 KB
This pack has been prepared to aid discussion and provide further
supplementary information only and has not been subject to an
external review or audit

-- 1 of 14 --

CUSTOMERS PER ENTITY
Life Policyholders
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Individual 449,300 447,690 449,130 449,020 449,378 448,313 445,813 446,713 452,561 446,475 440,747
Invest
Invest - DRO 137,718 137,189 135,819 134,721 133,741 132,817 131,244 129,606 127,831 124,135 120,253
Invest - Other 225,414 221,273 216,479 212,161 206,778 201,210 195,231 192,615 189,210 185,025 179,975
Group (lives) 707,756 711,161 680,754 584,081 562,769 576,450 562,440 578,035 551,219 544,443 539,552
Group schemes 2,647 2,663 2,666 2,793 2,844 2,827 2,825 2,797 2,740 2,771 2,635
Life NB APE
6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to
R million December 2022 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Individual 1,444 2,663 1,355 2,362 1,204 2,072 1,068 2,126 1,165 2,215 1,157
Group 75 175 130 181 64 193 94 160 75 97 55
Invest - Recurring 851 1,551 796 1,428 737 1,167 573 1,164 686 1,221 661
Invest - Single APE** 778 1,500 708 1,493 782 1,570 744 1,508 671 1,382 726
Total Life APE** 3,148 5,889 2,990 5,464 2,786 5,001 2,478 4,958 2,597 4,915 2,599
** APE shown at 10% of Single premium
Health Members
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
DHMS - Keycare 226,848 225,517 232,988 232,055 234,421 235,841 230,960 232,714 243,046 240,140 251,951
DHMS - Non-Keycare 1,147,016 1,149,861 1,142,556 1,135,853 1,118,591 1,111,545 1,099,553 1,111,079 1,108,674 1,110,401 1,098,903
In-House Schemes 321,333 319,813 321,838 318,246 316,973 321,613 321,767 319,974 317,408 316,410 315,875
Total 1,695,197 1,695,191 1,697,382 1,686,154 1,669,985 1,668,999 1,652,280 1,663,767 1,669,128 1,666,951 1,666,729
Health Lives
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
DHMS - Keycare 385,906 384,759 398,397 397,595 401,307 404,984 400,108 403,392 420,869 415,436 436,543
DHMS - Non-Keycare 2,402,336 2,413,851 2,412,595 2,406,528 2,383,486 2,375,082 2,358,232 2,381,735 2,387,237 2,394,336 2,382,596
In-House Schemes 710,485 707,406 710,427 704,472 699,342 707,293 704,749 698,534 689,688 686,114 677,530
Total 3,498,727 3,506,016 3,521,419 3,508,595 3,484,135 3,487,359 3,463,089 3,483,661 3,497,794 3,495,886 3,496,669
Vitality SA
December 2023 June 2023 December 2022* June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Total Vitality Health,
Vitality Drive and Vitality
Money programme lives
2,822,972 2,652,877 2,498,048 2,348,834 2,242,401 2,163,411 2,122,453 2,065,868 2,060,011 1,987,237 2,001,919
*restated to include for LA wellness figures
VitalityHealth Members
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Individual 138,278 135,117 129,568 124,395 117,007 113,189 108,955 105,915 104,997 101,702 96,277
SME 327,876 310,624 285,865 263,216 238,540 222,961 211,949 212,305 209,509 201,960 190,835
Corporate 112,941 108,191 102,823 99,578 89,881 86,149 80,514 81,124 78,050 70,583 61,970
Trust and Cost Plus 16,448 16,339 14,511 8,698 3,944 2,731 2,639 - - - -
Total 595,543 570,271 532,767 495,887 449,372 425,030 404,057 399,344 392,556 374,245 349,082
VitalityHealth Lives
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Individual 256,527 250,551 238,629 227,684 212,896 204,890 195,996 188,976 186,559 179,811 168,609
SME 522,753 496,299 460,442 429,110 395,777 374,179 357,768 356,907 353,763 342,431 327,594
Corporate 178,163 171,364 163,120 158,890 148,654 143,905 135,218 135,440 131,991 120,157 107,570
Trust and Cost Plus 27,349 26,854 22,673 15,903 6,509 4,066 3,956 - - - -
Total 984,792 945,068 884,864 831,587 763,836 727,040 692,938 681,323 672,313 642,399 603,773
VitalityLife Policies
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Policies 646,564 622,451 593,322 565,778 535,281 517,913 493,970 474,890 458,675 434,678 408,914
VitalityLife Lives
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Lives* 782,296 764,699 735,137 702,105 669,139 647,020 617,051 594,799 577,965 549,526 516,020
*restated to include unique lives only
Discovery Insure Policies
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Policies 215,297 211,223 214,315 213,453 212,570 202,335 191,936 178,517 169,920 159,171 152,947
Discovery Bank
December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 December 2018
Primary Clients 825,069 702,131 581,457 470,220 385,177 331,088 287,183 206,810 61,731 1,476 -
Total Accounts 1,933,839 1,625,912 1,312,970 1,023,790 793,215 648,546 521,081 357,416 141,660 3,740 -
2 Membership

-- 2 of 14 --

VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE
December 2023
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (253) (1,452) (754) (610) (3,069)
Value of In Force 659 1,739 999 510 3,907
Cost of Capital (21) (45) (53) (35) (154)
385 242 192 (135) 684
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 660 1,256 960 513 3,389
Cost of Capital (21) (45) (52) (28) (146)
639 1,211 908 485 3,243
June 2023
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (485) (2,757) (1,885) (1,701) (6,828)
Value of In Force 1,439 3,273 2,154 1,704 8,570
Cost of Capital (39) (87) (87) (89) (302)
915 429 182 (86) 1,440
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 1,434 2,575 1,745 1,907 7,661
Cost of Capital (38) (87) (95) (95) (315)
1,396 2,488 1,650 1,812 7,346
December 2022
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (231) (1,377) (815) (815) (3,238)
Value of In Force 762 1,754 895 919 4,330
Cost of Capital (20) (48) (38) (46) (152)
511 329 42 58 940
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 760 1,514 703 922 3,899
Cost of Capital (19) (48) (37) (55) (159)
741 1,466 666 867 3,740
June 2022
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (425) (2,590) (1,502) (1,378) (5,895)
Value of In Force 1,383 3,385 1,900 1,597 8,265
Cost of Capital (30) (90) (81) (108) (309)
928 705 317 111 2,061
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 1,368 2,934 1,482 1,577 7,361
Cost of Capital (30) (90) (81) (121) (322)
1,338 2,844 1,401 1,456 7,039
December 2021
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (205) (1,300) (677) (739) (2,921)
Value of In Force 596 1,765 783 839 3,983
Cost of Capital (13) (40) (32) (41) (126)
378 425 74 59 936
3 Value of New Business

-- 3 of 14 --

EV RECONCILIATION TO INCOME STATEMENT
for the half year ended 31 December 2023
R million
Embedded
Value
Earnings
Value of
In-Force
Cost of
required
Capital
Impact on
Income
Statement
Adjustment to
Shareholders
Funds
Statement of
Changes in
Equity
Total profit from new business 684 3,350 (154) (2,512)
- Health and Vitality 385 640 (21) (234) - -
- Life 242 1,289 (45) (1,002) - -
- VitalityHealth 192 941 (53) (696) - -
- VitalityLife (135) 480 (35) (580) - -
Profit from existing business
* Expected return 5,025 1,369 (39) 3,695
- Health and Vitality 1,911 399 1 1,511
Expected transfer from VIF to net worth - (1,511) - 1,511
Unwinding of the risk discount rate 1,911 1,910 1 -
- Life 2,259 1,419 (1) 841
Expected transfer from VIF to net worth - (841) - 841
Unwinding of the risk discount rate 2,259 2,260 (1) -
- VitalityHealth 415 (470) (22) 907
Expected transfer from VIF to net worth - (907) - 907
Unwinding of the risk discount rate 415 437 (22) -
- VitalityLife 440 21 (17) 436
Expected transfer from VIF to net worth - (436) - 436
Unwinding of the risk discount rate 440 457 (17) -
* Change in methodology and assumptions 666 (925) 626 965
- Health and Vitality (756) (773) 17 -
- Life (139) (1,126) (62) 1,049
- VitalityHealth 643 680 (37) -
- VitalityLife 918 294 708 (84)
* Experience variances 879 616 55 208
- Health and Vitality 299 18 (2) 283
- Life (50) 160 9 (219)
- VitalityHealth 414 236 47 131
- VitalityLife 216 202 1 13
Increase in goodwill and intangibles (110) - - - (110) -
Other initiatives 89 11 - 78 - -
Non-recurring expenses (159) - - (159) - -
Acquisition costs (19) (2) - (17) - -
Finance costs (1,662) - - (1,662) - -
Other (6) - - - (6) -
Foreign Exchange Rate Movements (478) (406) 24 155 80 (331)
Intangibles 69 - - - 69 -
DAC 11 - - - 11 -
Puttable NCI Liability - - - - - -
Other (558) (406) 24 155 - (331)
Return on shareholders' funds 893 - - 896 - (3)
Unrealised gain on investments and realised gain on investments
transferred to income statement 618 - - 621 - (3)
Health and Vitality investment income 51 - - 51 - -
Life investment income 224 - - 224 - -
VitalityHealth investment income - - - - - -
VitalityLife investment income - - - - - -
Amortisation of Intangibles (30) - - (212) 182 -
Amortisation of intangibles from business combinations (30) - - (45) 15 -
Amortisation of systems intangibles - - - (167) 167 -
VitalityHealth and VitalityLife DAC and unemployment reserve - - - 145 (145) -
Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - (73) 73 -
Life assets under insurance contracts - - - 1,256 (1,256) -
VitalityLife net assets under insurance contracts - - - 511 (511) -
Equity settled share based payment mark-to-market adjustment - - - 70 (70) -
Embedded value earnings 5,772 4,013 512 3,344 (1,763) (334)
Adjustment to Shareholders' Funds:
Change in: *
DAC 840
Intangibles & Goodwill 126
Life negative reserve 8,266
VitalityLife negative reserve 3,312
1 DP IFRS 16 financial lease accounting 73
Equity settled share based payment mark-to-market adjustment (70)
* The change in the adjustments to shareholder’s funds is a on a consistent IFRS 17 basis between 31 December 2023 and 30 June 2023. The reported change in adjustment to shareholder’s funds for 30
June 2023 and prior (in the Group EV Statement) is on an IFRS 4 basis.
4 EV recon

-- 4 of 14 --

EV BUILD-UP PER ENTITY
for the half year ended 31 December 2023
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total
Value of in-force business at 30 June 2023 25,473 31,636 12,099 10,682 - 79,890
Expected return (in-force business) 1,893 2,230 404 436 - 4,963
Release of profits (in-force business) (1,511) (841) (907) (436) - (3,695)
Value of new business 638 1,694 946 475 - 3,753
Expected return (new business) 18 29 11 4 - 62
Release of profits (new business) (19) (450) (58) (30) - (557)
Experience variances 16 169 283 203 - 671
Methodology changes (756) (1,188) 643 1,002 - (299)
Other - 9 (207) (175) - (373)
Value of in-force business at 31 December 2023 25,752 33,288 13,214 12,161 - 84,415
Shareholders’ funds per Balance Sheet 4,426 26,800 9,480 4,517 6,983 52,206
Adjustment to shareholders' funds - (17,225) (4,162) (8,751) (3,003) (33,141)
Embedded value at 31 December 2023 30,178 42,863 18,532 7,927 3,980 103,480
5 EV Buildup per Entity

-- 5 of 14 --

COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT
SHAREHOLDERS' FUNDS ON PUBLISHED BASIS
R million December 2023
1. Assets under insurance contracts
Discovery Life positive liabilities not netted off with negative liabilities*: 674
Discovery Life long term reserves in respect of policies with net negative liabilities: (27,780)
Working capital 175
Discovery Life liability for incurred claims (LIC) 7,029
Total Assets under insurance contracts: (19,901)
* The Discovery Retirement Optimiser pre-retirement matching strategy has been revised to consider portfolio cash flows available in the negative
reserve to match policies with positive reserves where appropriate by nature and duration. Whilst this does not change the overall IFRS liability it
results in a transfer of value from value of in-force to net worth on the embedded value basis.
2. Negative liabilites not included under assets under insurance contracts
Negative reserve in respect of Invest business (6,730)
DAC and DRL in respect of Invest business (745)
(7,475)
3. Components to be zeroised based on the Method of Distributable Cashflows:
Discovery Life long term reserves in respect of policies with net negative liabilities: (27,780)
Liabilities under reinsurance contracts** 444
Negative reserve in respect of Invest business (6,730)
DAC and DRL in respect of Invest business (745)
Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 5,307
Liabilities off set against Negative reserve before zeroisation 12,278
(17,225)
** This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts
zeroised based on the method of distributable cashflows.
4. Other adjustments to published Shareholders' funds
VitalityLife net assets under insurance contracts*** (8,739)
VitalityHealth and VitalityHealth Insurance Limited deferred acquisition costs (net of deferred tax)**** (4,162)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (12)
Goodwill (2,916)
Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential
Assurance Company joint venture (820)
Net preference share capital (779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 1,406
Equity settled share based payment mark-to-market adjustment 106
Adjustment to Shareholders' funds from published basis (33,141)
***For periods prior to June 2022, the “Vitality Life Limited net assets under insurance contracts” included an adjustment for the Discovery funded
VitalityLife business on the
Prudential Assurance Company licence net assets under insurance contracts. From 30 June 2022, the Discovery funded VitalityLife business on the
Prudential licence net assets under insurance contracts are no longer eliminated in the embedded value because the Discovery funding was settled
as part of the agreement to delay the Part VII transfer in the period, aligning the financial operation of all VitalityLife business on the Prudential
Assurance Company licence.
6 EV Adjustment to SH funds

-- 6 of 14 --

BREAKDOWN OF INVEST ASSETS UNDER ADMINISTRATION
R million Total
December 2021 127,632
June 2022 121,737
December 2022 130,830
June 2023 140,378
December 2023 144,810
7 Invest AUA

-- 7 of 14 --

VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST
R million December 2023 June 2023 December 2022 June 2022 December 2021
VIF**
Life 22,859 22,244 23,133 22,059 20,467
Invest 10,429 9,393 9,521 8,505 9,524
APE***
Life 426 823 463 837 407
Invest 1,150 2,142 1,033 2,158 1,130
VNB**
Life 136 162 169 364 227
Invest 106 267 160 341 198
*Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later periods.
** These VIF and VNB numbers are after allowing for the Cost of required Capital.
***APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in relation to
New Business only, and excludes any addition to Existing Business premiums arising from servicing increases and ACIs.
8 Results split Life and Invest

-- 8 of 14 --

RECONCILIATION TO THE REQUIRED CAPITAL
for the half year ended 31 December 2023
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Opening - 30 June 2023 1,108 26,011 4,238 10,630 41,987
- -
- Methodology and Basis Changes - 421 - 272 693
- Expected release on in-force at start of period (15) (224) (108) (231) (578)
- Impact of new business written 55 537 284 606 1,482
- Other changes* 11 971 (28) (1,070) (116)
- Exchange rate movements - - (74) (197) (271)
Change in Required Capital 51 1,705 74 (620) 1,210
- - - - -
Closing - 31 December 2023 1,159 27,716 4,312 10,010 43,197
*This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required
capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only.
For VitalityLife, this line includes the release of the 1.5 times the UK Solvency I long-term insurance capital requirement associated with the
VitalityLife business on the PAC license.
9 Recon of Required Capital

-- 9 of 14 --

Segmental information
for the half year ended 31 December 2023
SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS
R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL
Income statement
Insurance premium revenue 193 8 595 1 866 2 792 - 7 960 4 368 343 26 117 - 26 117
- Contracts measured under GMM/ VFA - 6 859 1 866 - - - 4 368 - 13 093 - 13 093
- Contracts measured under PAA 193 1 736 - 2 792 - 7 960 - 343 13 024 - 13 024
Insurance service expenses -139 -7,489 -1,174 -2,810 - -7,197 -3,768 -376 -22,953 - -22,953
-Claims and benefits -77 -5,700 -202 -1,838 - -4,297 -2,281 -236 -14,631 - -14,631
- Insurance service expense and other -62 -819 -525 -452 - -2,051 -209 -140 -4,258 - -4,258
- Insurance acquisition cash flows - -970 -447 -520 - -849 -1,278 - -4,064 - -4,064
Insurance service result (pre-reinsurance) 54 1,106 692 -18 - 763 600 -33 3,164 - 3,164
Net expense/income from reinsurance contracts - -410 - 19 - -5 -214 1 -609 - -609
Reinsurance expense - -1,800 - -249 - -5 -2,675 -135 -4,864 - -4,864
- Insurance claims recovered from reinsurers - 1,390 - 268 - - 2,461 136 4,255 - 4,255
Insurance service result 54 696 692 1 - 758 386 -32 2,555 - 2,555
Net financial result from insurance finance income and expense - 1,318 -3,939 - - - 76 - -2,545 -347 -2,892
- Net finance income/ (expense) from insurance contracts - 1,414 -3,939 - - - 142 - -2,383 -347 -2,730
- Net finance expense from reinsurance contracts - -96 - - - - -66 - -162 - -162
Investment income on assets backing policyholder liabilities - 10 26 103 - 83 41 10 273 139 412
Net fair value (losses)/ gains on financial instruments at fair value through profit or loss -4 520 3,911 4 - 56 - 424 4,911 1,759 6,670
Fair value adjustments to liabilities under investment contracts - -1 -260 - - - - -430 -691 - -691
Third party interest fair value adjustments to liabilities under investment contracts - - - - - - - - - -1,149 -1,149
Inter-segment funding1 -121 121 - - - - - - -
Other gains on financial instruments - - - - 5 - - - 5 - 5
Net insurance and investment results 50 2,422 551 108 5 897 503 -28 4,508 402 4,910
Fee income from administration businesses 4 452 - 812 4 - 25 - 1 610 6 903 - 6 903
Vitality income - - - - - 301 131 1,703 2,135 - 2,135
Net banking fee and commission income - - - - 567 - - 14 581 - 581
- Banking fee and commission income 1 - - - - 845 - - - 845 - 845
- Banking fee and commission expense - - - - ( 278) - - 14 ( 264) - ( 264)
Net bank interest and similar income - - - - 366 - - - 366 - 366
- Bank interest and similar income using the effective interest rate - - - - 869 - - - 869 - 869
- Bank interest and similar expense using the effective interest rate - - - - -503 - - - -503 - -503
Other income 689 1 - 11 - 12 - 66 779 - 779
Non-insurance revenue and income 5,141 1 812 15 933 338 131 3,393 10,764 - 10,764
Net income 5 191 2 423 1 363 123 938 1 235 634 3 365 15 272 402 15 674
Acquisition costs - - -402 - - - - -54 -456 - -456
Expected credit losses - - - - -93 - - - -93 - -93
Marketing and administration expenses
- depreciation and amortisation -79 - -7 -35 -175 -228 -23 -409 -956 -84 -1,040
- derecognition of intangible assets and property and equipment - - - -3 - -1 - -4 -8 - -8
- impairment of intangible assets and property and equipment - - - - - - - - - - -
- other expenses -3,238 -156 -334 -84 -1,009 -480 -221 -2,917 -8,439 -86 -8,525
Share of net profits from equity-accounted investments - - - 19 - 1 - 282 302 -24 278
Normalised profit/(loss) from operations 1 874 2 267 620 20 ( 339) 527 390 263 5 622 208 5 830
Investment income earned on shareholder investments and cash 54 13 6 - - - - 66 139 ( 139) -
Intercompany investment income - - - - - - - 823 823 ( 823) -
Net fair value gains/(losses) on financial assets at fair value through profit or loss - 29 27 - - - - - 56 ( 56) -
Amortisation of intangibles from business combinations - - - ( 24) - - - ( 28) ( 52) 52 -
Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - -59 -59 59 -
Restructuring costs - - - - - - - -20 -20 20 -
Finance costs -11 -1 - - - -8 -112 -749 -881 -144 -1,025
Intercompany finance costs -201 - - - - - -227 -395 -823 823 -
Foreign exchange gains 1 -4 -12 - - - - -25 -40 - -40
Profit/(loss) before tax 1 717 2 304 641 ( 4) ( 339) 519 51 ( 124) 4 765 - 4 765
Income tax expense -470 -612 -228 -1 108 -152 -26 -41 -1,422 - -1,422
Profit/(loss) for the period 1 247 1 692 413 ( 5) ( 231) 367 25 ( 165) 3 343 - 3 343
IFRS REPORTING
ADJUSTMENTS
10 Segmental FY 2023

-- 10 of 14 --

Group Shareholder Free Cash Movement
R millions HY2024 FY2023 HY2023
Cash Generated from In-Force Before Financing and Tax* 8,988 16,692 7,949
Tax Paid (792) (1,839) (1,042)
Finance Cost Paid (802) (1,501) (786)
Dividends Paid (783) (69) (31)
New Business (5,294) (9,515) (4,502)
New Initiatives (776) (1,671) (800)
Investment in Ping An Health - - -
Business Development & Other ^ (864) (1,274) (435)
Share Issue (Net of Share Issue Costs) - - -
Transactions with Reinsurers 13 171 198
Transactions with Borrowers (Excl. Finance Costs)* (80) (597) (463)
Movement in Shareholder Free Cash (390) 397 89
Remove ordinary shareholder dividend paid in shareholder cash flow period 739 - -
Add ordinary shareholder dividend paid in respect of shareholder cash flow period (440) (739) -
Movement in Shareholder Free Cash – Dividend Accrual Basis** (91) (342) 89
Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period
R millions HY2024 FY2023 H1 FY2023
Profit for the period 3,343 5,320 2,943
-
Reverse non-cash profit items: -
Share of net profits/(losses) from equity accounted investments (302) (561) (76)
Gains from dilution of equity accounted investments - 5 -
Depreciation and amortisation 1,040 1,972 957
Impairment of intangible assets 4 61 4
Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) - (42) (14)
Movement in contract assets (252) 52 31
Deferred Revenue (Excl. exchange rate movements) - - -
Amortisation of intangibles from business combinations - 56 27
Non cash impact of Vitality Health DAC (206) (753) (292)
Non-cash fair value gains on financial assets (56) (214) (43)
UK Life IFRS reporting adjustments - Tax Accrued - - -
Non-cash forex gains / losses - 9 (1)
Other non-cash adjustments to profit * (64) (178) (44)
-
Adjustments from IFRS to EV ANW: - -
Tangible Asset Release on Transition to SAM - - -
Gain from Asset-Liability optimisation - - -
Increase in Negative Reserves and Invest DAC (Net of tax) (1,767) (4,141) (1,735)
Exchange rate movements on Vitality Life Negative Reserves (137) 1,900 195
Other adjustments to arrive at EV ANW 137 196 104
-
Incurred to Cash basis: -
- Rent Paid (286) (328) (158)
- Finance Costs Paid (802) (1,501) (932)
- Finance Costs Accrued 1,025 1,941 930
- Taxation paid (792) (1,839) (1,042)
- Taxation Accrued 810 1,495 741
-
Investing Activities: -
Purchase of property and equipment (246) (551) (210)
Proceeds from disposal of property and equipment - 2 2
Purchase of intangible assets (800) (1,760) (751)
Proceeds from disposal of intangible assets - - -
Increase in investment in associate (176) (75) (53)
Investment in Ping An Health - - -
Card and Bank Buy-out Payment - - -
Cash proceeds from CMT transaction - - -
Acquisition of business net of cash required - (3) -
-
Financing Activities: -
Increase in borrowings 500 7,441 3,855
Elimination of borrowings not allocated to shareholder cash - - -
Repayment of borrowings* (580) (8,038) (4,318)
Share Issue (Net of Share Issue Costs) - - -
Dividends paid to ordinary shareholders (739) - -
Dividends paid to preference shareholders (44) (69) (31)
- -
Movement in Shareholder Free Cash (390) 397 89
Notes
(1) "Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the
Embedded Value. Changes in working capital are not allowed for in the estimate.
(2) * HY2023 and FY2023: Reallocation of rental paid on finance leases from "Transactions with Borrowers" to "Cash Generated from In-Force". This value was immaterial in all other periods.
(3) ** This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For 31 December 2023, the
declared dividend of R440m, per the interim financial results, is used as the dividend accrued in respect of the six month period.
(4) ^ In previous disclosures, this line was net off against Cash Generated from In-Force Before Financing and Tax

-- 11 of 14 --

Reconciliation of operating profit to normalised operating profit
for the half year ended 31 December 2023
Group Group
half year
ended
December
2023
half year
ended
December
2022 %
R million Unaudited Unaudited change
Operating profit before integral equity-accounted investments per income statement 5,552 5,464 2%
Share of net profits from equity accounted investments 278 55
Impairment of goodwill
Normalised profit from operations per segmental (IFRS total) 5,830 5,519 6%
Normalised profit adjustments ( 208) ( 546)
Investment income earned on shareholder investments and cash ( 139) ( 102)
Difference between market related rental and depreciation and finance costs (Head office) ( 85) ( 73)
Net fair value gains on financial assets at fair value through profit or loss ( 56) ( 30)
VitalityLife interest rate derivative ( 391)
Amortisation of intangibles from business combinations 52 50
Restructuring costs 20
Other
Normalised profit from operations 5,622 4,973 13%
12 Op Profit recon

-- 12 of 14 --

NAV PER ENTITY
for the half year ended 31 December 2023
Covered businesses December 2023
NAV before adjustment to shareholder funds
Health and Vitality 4,426
Life and Invest 26,800
VitalityHealth 9,480
VitalityLife 4,517
Non-covered business
Bank, including DCS intangible asset and goodwill 7,641
Insure 1,935
PAHI 6,173
CMT 1,369
Limited (9,590)
Other (545)
Total NAV 52,206

-- 13 of 14 --



-- 14 of 14 --